Previous 10 | Next 10 |
OTCQX:AAUKF , ABEV , ABG , AGCO , OTCPK:AIQUF , ALGM , ALLE , ALNY , AMT , AOS , ARCH , ARES , ARGX , ASPS , ASX , OTCPK:ATGFF , ATNX , BAX , BC , BCS , BEN , BFH , BPOP , BT , BTU , BUD ...
Smith+Nephew to showcase latest innovations for sports medicine joint repair at 2022 AOSSM Annual Meeting PR Newswire LONDON , July 13, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN) (NYSE: SNN), the global medical technology company, today announces a robus...
Shares have not been this oversold for decades. 70%+ gross margin business along with strong return on capital metrics has us interested here. Valuation becoming very attractive. We may buy here on a convincing swing low. Intro If we look at a long-term chart of ...
Smith+Nephew ( NYSE: SNN ) said it launched an app called Wound Compass to help reduce practice variation in wound care. The British medical device maker said the clinical support app is a for health care professionals to help them in wound assessment and decision...
Smith+Nephew launches Clinical Support App to help reduce practice variation in wound care PR Newswire LONDON , July 12, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the WOUND C...
Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System PR Newswire LONDON , June 30, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company...
Argus Research has started Enovis Corp. (NYSE:ENOV) with a hold rating as it has concerns about EPS growth and "steep competition" from medical device peers. The firm does not have a price target. Analyst John Eade said that Enovis' record on EPS growth is not as strong as rivals, adding that...
SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS PR Newswire LONDON , June 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE...
Bioventus' diversified portfolio insulates the company from peers and enables it to innovate around its core offering. The company holds market-leading positions in several complex pain segments, offering non-invasive treatment solutions. There are high earnings and FCF growth pot...
Smith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION PR Newswire LONDON , June 8, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology busine...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...